380 related articles for article (PubMed ID: 28911083)
61. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).
Kjällquist U; Erlandsson R; Tobin NP; Alkodsi A; Ullah I; Stålhammar G; Karlsson E; Hatschek T; Hartman J; Linnarsson S; Bergh J
BMC Cancer; 2018 Feb; 18(1):174. PubMed ID: 29433456
[TBL] [Abstract][Full Text] [Related]
62. FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ
Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815
[TBL] [Abstract][Full Text] [Related]
63. Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis.
Liu J; Cho YB; Hong HK; Wu S; Ebert PJ; Bray SM; Wong SS; Ting JC; Calley JN; Whittington CF; Bhagwat SV; Reinhard C; Wild R; Nam DH; Aggarwal A; Lee WY; Peng SB
Sci Rep; 2020 Jul; 10(1):10725. PubMed ID: 32612211
[TBL] [Abstract][Full Text] [Related]
64. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
[TBL] [Abstract][Full Text] [Related]
65. Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.
Lee WC; Reuben A; Hu X; McGranahan N; Chen R; Jalali A; Negrao MV; Hubert SM; Tang C; Wu CC; Lucas AS; Roh W; Suda K; Kim J; Tan AC; Peng DH; Lu W; Tang X; Chow CW; Fujimoto J; Behrens C; Kalhor N; Fukumura K; Coyle M; Thornton R; Gumbs C; Li J; Wu CJ; Little L; Roarty E; Song X; Lee JJ; Sulman EP; Rao G; Swisher S; Diao L; Wang J; Heymach JV; Huse JT; Scheet P; Wistuba II; Gibbons DL; Futreal PA; Zhang J; Gomez D; Zhang J
Genome Biol; 2020 Nov; 21(1):271. PubMed ID: 33148332
[TBL] [Abstract][Full Text] [Related]
66. Genomic Heterogeneity and Clonal Evolution in Gastroesophageal Junction Cancer Revealed by Single Cell DNA Sequencing.
Duan Q; Tang C; Ma Z; Chen C; Shang X; Yue J; Jiang H; Gao Y; Xu B
Front Oncol; 2021; 11():672020. PubMed ID: 34046362
[TBL] [Abstract][Full Text] [Related]
67. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions.
Brannon AR; Vakiani E; Sylvester BE; Scott SN; McDermott G; Shah RH; Kania K; Viale A; Oschwald DM; Vacic V; Emde AK; Cercek A; Yaeger R; Kemeny NE; Saltz LB; Shia J; D'Angelica MI; Weiser MR; Solit DB; Berger MF
Genome Biol; 2014 Aug; 15(8):454. PubMed ID: 25164765
[TBL] [Abstract][Full Text] [Related]
68. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
[TBL] [Abstract][Full Text] [Related]
69. Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma.
Yamamoto S; Midorikawa Y; Morikawa T; Nishimura Y; Sakamoto H; Ishikawa S; Akagi K; Aburatani H
Genes Chromosomes Cancer; 2010 May; 49(5):487-96. PubMed ID: 20175194
[TBL] [Abstract][Full Text] [Related]
70. An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
Faugeroux V; Lefebvre C; Pailler E; Pierron V; Marcaillou C; Tourlet S; Billiot F; Dogan S; Oulhen M; Vielh P; Rameau P; NgoCamus M; Massard C; Laplace-Builhé C; Tibbe A; Taylor M; Soria JC; Fizazi K; Loriot Y; Julien S; Farace F
Eur Urol Oncol; 2020 Aug; 3(4):498-508. PubMed ID: 31412010
[TBL] [Abstract][Full Text] [Related]
71. Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.
Nagahashi M; Wakai T; Shimada Y; Ichikawa H; Kameyama H; Kobayashi T; Sakata J; Yagi R; Sato N; Kitagawa Y; Uetake H; Yoshida K; Oki E; Kudo SE; Izutsu H; Kodama K; Nakada M; Tse J; Russell M; Heyer J; Powers W; Sun R; Ring JE; Takabe K; Protopopov A; Ling Y; Okuda S; Lyle S
Genome Med; 2016 Dec; 8(1):136. PubMed ID: 28007036
[TBL] [Abstract][Full Text] [Related]
72. Intratumor heterogeneity in colorectal cancer: Distribution of tumor suppressor gene variants with regard to patient lymph node status.
Wątor G; Seweryn M; Kapusta P; Świrta J; Wałęga P; Barczyński M; Wołkow PP
Clin Genet; 2023 Oct; 104(4):406-417. PubMed ID: 37339860
[TBL] [Abstract][Full Text] [Related]
73. [Poly-G for tumor matched samples chronicles the evolution of human colorectal cancer].
Gao X; Yu T; Zhang Q; Zhang SY; Huang D; Zhao XY; Liu G
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):382-388. PubMed ID: 37188622
[No Abstract] [Full Text] [Related]
74. Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity.
Shi W; Ng CKY; Lim RS; Jiang T; Kumar S; Li X; Wali VB; Piscuoglio S; Gerstein MB; Chagpar AB; Weigelt B; Pusztai L; Reis-Filho JS; Hatzis C
Cell Rep; 2018 Nov; 25(6):1446-1457. PubMed ID: 30404001
[TBL] [Abstract][Full Text] [Related]
75. [Multiregion sequencing reveals intratumor heterogeneity in esophageal squamous cell carcinoma].
Cao W; Wu W; Yan M; Tian F; Liu HS; Wang JW; Zhang QW; Li YJ; Li M
Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):660-6. PubMed ID: 27647397
[TBL] [Abstract][Full Text] [Related]
76. Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome.
Venet D; Fimereli D; Rothé F; Boeckx B; Maetens M; Majjaj S; Rouas G; Capra M; Bonizzi G; Contaldo F; Galant C; Piccart M; Pruneri G; Larsimont D; Lambrechts D; Desmedt C; Sotiriou C
EBioMedicine; 2020 Jun; 56():102793. PubMed ID: 32512508
[TBL] [Abstract][Full Text] [Related]
77. Dissecting the heterogeneities of the tumor microenvironment between metastatic and nonmetastatic primary colorectal cancer patients by single-cell RNA sequencing.
Wang S; Deng S; Jin X; Chen W; Wang X; Zhan H; Fang X; Fu J
Life Sci; 2023 May; 320():121576. PubMed ID: 36933827
[TBL] [Abstract][Full Text] [Related]
78. Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer.
He WZ; Hu WM; Wang F; Rong YM; Yang L; Xie QK; Yang YZ; Jiang C; Qiu HJ; Lu JB; Zhang B; Ding PR; Xia XJ; Shao JY; Xia LP
J Natl Compr Canc Netw; 2019 Oct; 17(10):1174-1183. PubMed ID: 31590148
[TBL] [Abstract][Full Text] [Related]
79. Genome variation in colorectal cancer patient with liver metastasis measured by whole-exome sequencing.
Yi H; Liao ZW; Chen JJ; Shi XY; Chen GL; Wu GT; Zhou DY; Zhou GQ; Huang JY; Lian L; Yu ZY; He SB
J Gastrointest Oncol; 2021 Apr; 12(2):507-515. PubMed ID: 34012644
[TBL] [Abstract][Full Text] [Related]
80. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
